Скачать или смотреть The Stock of the Day is Telix Pharmaceuticals (ASX: TLX)

Telix Pharmaceuticals (ASX: TLX) has reported a profit of $29.7M for H1 of FY24, reporting a loss of $14.3M in the same period last year. Gross margins improved 66% as the selling price for their prostate cancer imaging product stabilized with the company following what it described as "a disciplined cost control". Full year guidance has of $490M-$510M USD has been reaffirmed. Our experts, Mathan Somasundaram from Deep Data Analytics and Kai Chen from MPC Markets, share their views on the stock. Mathan says that it's a great company, but when investing in a sector such as biotech, the best thing is to pick them early and if you've missed out? Best to move on. Kai agrees saying that the important thing to remember is that if you're in it, there's a lot of downside risk when it is trading at the levels it is. So will it be a buy, hold or sell?

Watch the full episode here: https://ausbiz.co/thecall-2308

Stocks covered on today's episode of 'the call':
Stanmore Resources (SMR)
Ampol (ALD)
CAR Group (CAR)
Reliance Worldwide Corporation (RWC)
G8 Education (GEM)
Brainchip (BRN)
Judo Capital Holdings (JDO)
Suncorp Group (SUN)
Qualitas (QAL)
Acrow (ACF)

Trade your Stock of the Day with IG: https://ausbiz.co/IG_AU

Subscribe to ausbiz:
the COB newsletter - https://company.ausbiz.com.au/newsletter
ausbiz channel - https://www.ausbiz.com.au/
X: https://x.com/ausbiztv
Facebook:   / ausbiztv  

#asx #sharemarket #stocks #ausbiz #shares #investing #equities #hotstocks #stockpicking #australiastocktrading #asxdividend stocks #etfinvesting